Exclusive: Ferring eyes expansion with 25 million-euro India facility

Ferring Pharma is looking at building a commercial as well as manufacturing headquarters in India over the next two-three years, chief operating officer Michael Pettigrew told The Pharma Letter in an interview.

The interview followed a media briefing, a first for the Saint-Prex, Switzerland-based company.

“We are building that plant for two reasons. First, we needed a back-up plant for our facility in Denmark, and India provided us the opportunity to reduce our cost, not immediately, but over time," Mr Pettigrew said.

According to reports, the drug industry in India is primarily driven by some of the leading foreign companies via subsidiaries on the back of availability of cheap labor. The Indian pharmaceutical industry is the world's second-largest by volume even though the number of purely Indian pharma companies is fairly low.